Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 1/20 | 0.49 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 4/20 | 0.35 |
| ▸ | NCEH1 | Q6PIU2 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.33 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.33 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30552290 | 1.00 | FABP3 (0.49) | FABP3MRGPRX4CYP3A4MAPK1TSHR | |
| SCHEMBL11013172 | 0.90 | FABP3 (0.43) | FABP3MRGPRX4CYP3A4MAPK1TSHR | |
| SCHEMBL2929232 | 0.86 | FABP3 (0.49) | FABP3MRGPRX4CYP3A4MAPK1TSHR | |
| SCHEMBL31105888 | 0.84 | FABP3 (0.51) | FABP3MRGPRX4CYP3A4MAPK1TSHR | |
| SCHEMBL121773 | 0.84 | FABP3 (0.51) | FABP3MRGPRX4CYP3A4MAPK1TSHR | |
| SCHEMBL2849811 | 0.84 | FABP3 (0.47) | FABP3MRGPRX4CYP3A4MAPK1TSHR | |
| SCHEMBL10911280 | 0.84 | FABP3 (0.46) | FABP3MRGPRX4TSHRNPC1RAB9A | |
| SCHEMBL31612516 | 0.83 | KDM4E (0.50) | FABP3MRGPRX4CYP3A4MAPK1TSHR | |
| SCHEMBL5790540 | 0.83 | FABP3 (0.46) | FABP3MRGPRX4CYP3A4MAPK1TSHR | |
| SCHEMBL8860109 | 0.83 | KDM4E (0.50) | FABP3MRGPRX4CYP3A4MAPK1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1706 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103068853-B | Synergistic biomolecule-polymer conjugates | PEG生物制药公司 | 2016-08-10 | — | — | CN | claimed |
| US-20160017058-A1 | BISPECIFIC ANTIBODIES AND USES THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-01-21 | — | — | US | claimed |
| EP-2970505-A1 | BISPECIFIC ANTIBODIES AND USES THEREOF | The California Institute for Biomedical Research (US) | 2016-01-20 | — | — | EP | claimed |
| WO-2014153002-A1 | BISPECIFIC ANTIBODIES AND USES THEREOF | THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH (US) | 2014-09-25 | — | — | WO | claimed |
| US-20100112660-A1 | Method for Derivatization of Proteins Using Hydrostatic Pressure | BAROFOLD, INC. (US) | 2010-05-06 | — | — | US | claimed |
| WO-2009155102-A2 | METHOD FOR DERIVATIZATION OF PROTEINS USING HYDROSTATIC PRESSURE | BAROFOLD, INC. (US) | 2009-12-23 | — | — | WO | claimed |
| EP-1200178-B1 | COMPOSITE MEMBRANE WITH POLYALKYLENE OXIDE MODIFIED POLYAMIDE SURFACE | DOW GLOBAL TECHNOLOGIES INC (US) | 2008-11-12 | — | — | EP | claimed |
| EP-1493456-A2 | Drug release stent coating and process | Boston Scientific Scimed, Inc. (US) | 2005-01-05 | — | — | EP | claimed |
| EP-1479401-A2 | Drug release stent coating and process | Boston Scientific Scimed, Inc. (US) | 2004-11-24 | — | — | EP | claimed |
| EP-1200178-A1 | COMPOSITE MEMBRANE WITH POLYALKYLENE OXIDE MODIFIED POLYAMIDE SURFACE | THE DOW CHEMICAL COMPANY (US) | 2002-05-02 | — | — | EP | claimed |
| US-6280853-B1 | CROSSLINKED POLYAMIDES ON SUPPORTS WITH GRAFTING POLYOXYALKYLENE OXIDE GROUPS | THE DOW CHEMICAL COMPANY | 2001-08-28 | — | — | US | claimed |
| WO-2000076641-A1 | COMPOSITE MEMBRANE WITH POLYALKYLENE OXIDE MODIFIED POLYAMIDE SURFACE | THE DOW CHEMICAL COMPANY (US) | 2000-12-21 | — | — | WO | claimed |
| EP-0832655-A2 | Drug release stent coating and process | SCHNEIDER (USA) INC. (US) | 1998-04-01 | — | — | EP | claimed |
| JP-2153928-A | — | — | None | — | — | JP | disclosed |
| JP-2153929-A | — | — | None | — | — | JP | disclosed |
| EP-4104853-B1 | ARGININE DEIMINASE WITH REDUCED CROSS-REACTIVITY TOWARD ADI - PEG 20 ANTIBODIES FOR CANCER TREATMENT | POLARIS GROUP (KY) | 2026-05-06 | — | — | EP | disclosed |
| US-4001175-A | ADDITIVES OF METAL SALTS OF SULFONIC ACIDS OF AROMATIC SULFOXIDES | GENERAL ELECTRIC COMPANY (US) | 1977-01-04 | — | — | US | disclosed |
| US-3971756-A | SILOXANE, ORGANIC ALKALI OR ALKALINE EARTH SALTS | GENERAL ELECTRIC COMPANY (US) | 1976-07-27 | — | — | US | disclosed |
| US-3945967-A | ALKYL PHOSPHITE, EPOXY COMPOUND | GENERAL ELECTRIC COMPANY (US) | 1976-03-23 | — | — | US | disclosed |
| US-3933730-A | POLYDIMETHYLSILOXANE GUM, DIVIDED SILICA | GENERAL ELECTRIC COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160017058-A1 | BISPECIFIC ANTIBODIES AND USES THEREOF | FCGR3B, CD22, CD14 | FABP3 1480/4885MRGPRX4 349/4885CYP3A4 4793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.